https://doi.org/10.55788/0ec0fd0c
“Elderly patients with AF in rural China are difficult to reach due to their low educational level, limited access to information technology, long travel time to hospitals, and travel difficulties,” explained Prof. Minglong Chen (First Affiliated Hospital of Nanjing Medical University, China) [1]. “The only way we can reach them is to empower village doctors to provide good quality chronic disease care.”
Prof. Chen and colleagues designed a novel integrated AF care model that connects AF specialists and village doctors through telemedicine to deliver quality AF care. The cluster-randomised MIRACLE-AF trial (NCT04622514) tested the value of this care model with 1,039 participants from 30 villages. The participants were randomised to the telemedicine arm or to usual care. The first primary outcome was adherence to the ABC pathway at 12 months (i.e. Avoid stroke by appropriately using anticoagulant therapy, Better symptom management with patient-centred symptom-directed rhythm or rate control, and Cardiovascular and comorbidity risk factor management). The second primary outcome was a composite of cardiovascular events at 36 months.
At 12 months, adherence to the ABC pathway was significantly increased in the intervention arm compared with the control arm (33.1% vs 8.7%; P<0.001). This effect was driven by the uptake of anticoagulation therapy in the telemedicine arm (85.2% vs 20.8%; P<0.001). Furthermore, participants in the intervention arm had fewer cardiovascular events at 3 years of follow-up than those in the control arm (6.2% vs 9.6% per year; HR 0.64; 95% CI 0.50–0.82; P<0.01).
Annual cardiovascular death (1.7% vs 3.4%; HR 0.50; 95% CI 0.32–0.80; P=0.004), annual stroke rate (1.5% vs 2.4%; HR 0.64; 95% CI 0.41–1.00; P=0.049), and annual hospitalisation due to heart failure or acute coronary syndrome (3.2% vs 4.7%; HR 0.69; 95% CI 0.49–0.95; P=0.025) were all significantly lower in the telemedicine arm than in the control arm.
“The MIRACLE-AF model appears to be a well-rounded solution for improving AF care delivery that could be generalised to the older population across rural China and other low- and middle-income countries with limited healthcare access,” concluded Prof. Chen.
- Chen M, et al. A novel model of integrated care of older patients with atrial fibrillation on cardiovascular outcomes in rural China. HOTLINE 9, ESC Congress 2024, 30 Aug–02 Sept, London, UK.
Copyright ©2024 Medicom Medical Publishers
Posted on
Previous Article
« SUPPRESS-AF: What is the value of adding LVA ablation to PVI in AF? Next Article
OCEANIC-AF: Asundexian inferior to apixaban for ischaemic stroke prevention in AF »
« SUPPRESS-AF: What is the value of adding LVA ablation to PVI in AF? Next Article
OCEANIC-AF: Asundexian inferior to apixaban for ischaemic stroke prevention in AF »
Table of Contents: ESC 2024
Featured articles
Meet the Expert: Dr Abdullahi Mohamed on Iron Deficiency in Patients with HF
2024 ESC Guidelines in a Nutshell
Guidelines for the management of elevated blood pressure and hypertension
Guidelines for the management of chronic coronary syndromes
Guidelines for the management of atrial fibrillation
Guidelines for the management of peripheral artery and aortic diseases
Crossing Borders in Arrhythmia
EPIC-CAD: What is the best antithrombotic approach in high-risk AF plus stable CAD?
OCEANIC-AF: Asundexian inferior to apixaban for ischaemic stroke prevention in AF
MIRACLE-AF: Elegant solution to improve AF care in rural China
SUPPRESS-AF: What is the value of adding LVA ablation to PVI in AF?
Clever Ideas for Coronary Artery Disease
ABYSS: Can beta-blocker safely be interrupted post-MI?
SWEDEGRAFT: Can a no-touch vein harvesting technique improve outcomes in CABG?
Bioadaptor meets expectations in reducing target lesion failures in coronary artery disease
REC-CAGEFREE I: Can we avoid permanent stenting with drug-coated balloons?
OCCUPI: OCT-guided PCI improves outcomes in complex CAD
Highway to Hypertension Control
Low-dose 3-drug pill GMRx2 shows promise in lowering BP
Is administering BP medication in the evening better than in the morning?
VERONICA: Improving BP control in Africa with a simple strategy
High-end Trials in Heart Failure
FINEARTS-HF: Finerenone improves outcomes in heart failure with preserved ejection fraction
MRAs show varied efficacy in heart failure across ejection fractions
MATTERHORN: Transcatheter repair matches surgery for HF with secondary mitral regurgitation
RESHAPE-HF2: Not a “tie-breaker” for TEER in heart failure
Practical Gains in Screening and Diagnostics
STEEER-AF: Shockingly low adherence to ESC atrial fibrillation guidelines
SCOFF: To fast or not to fast, that’s the question
WESTCOR-POC: Point-of-care hs-troponin testing increases emergency department efficiency
PROTEUS: Can AI improve decision-making around stress echocardiography?
RAPIDxAI: Can AI-augmented chest pain assessment improve cardiovascular outcomes?
Miscellaneous Achievements in Cardiology
HELIOS-B: Vutrisiran candidate for SoC in ATTR cardiomyopathy
Does RAS inhibitor discontinuation affect outcomes after non-cardiac surgery?
Novel approach to managing severe tricuspid regurgitation proves its value
NOTION-3: TAVI plus PCI improves outcomes in CAD plus severe aortic stenosis
RHEIA: TAVI outperformed surgery in women with aortic stenosis
Related Articles
November 7, 2024
HELIOS-B: Vutrisiran candidate for SoC in ATTR cardiomyopathy
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com